Sensex gives up 51K amid broad-based sell-off, dips 435 pts; PSBs, auto hit

The Nifty PSU bank index ended as the top laggard on the NSE, down 4.7 per cent, after surging nearly 6 per cent each over the past two days

12:30 PM

Zydus Cadila gets USFDA final nod for low blood pressure drug Droxidopa

Zydus Cadila on Friday said it has received final approval from the US health regulator to market Droxidopa capsules, used to treat low blood pressure. Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Droxidopa capsules in the strength of 100 mg, 200 mg, and 300 mg, Cadila Healthcare said in a regulatory filing. READ MORE

12:24 PM

Ashok Leyland starts commercial production of the buses at Vijayawada plant

12:16 PM

Pumping in $33.8 bn so far this fiscal, FPIs' holding at record $592.5 bn

The maximum holding is in financial services sector at USD 191.3 billion, followed by software (USD 76.1 billion), oil & gas (USD 50 billion), automobiles & auto components (USD 26.9 billion, pharmaceuticals & biotechnology (USD 22.8 billion), sovereign (USD 21.7 billion--debt), household & personal products (USD 20.2 billion), capital goods (USD 19.8 billion), food, beverages & tobacco (USD 15.7 billion) and insurance (USD13.4 billion). READ MORE

12:11 PM

MARKET UPDATE:: Small-caps outperform

11:59 AM

IDFC First Bank gains 9%, hits 52-week high as board approves fund raising

Shares of IDFC First Bank hit a fresh 52-week high of Rs 63.05, up 9 per cent in the intra-day trade, on the BSE on Friday after the bank's board approved raising up to Rs 3,000 crore. "The Board at its meeting held on Thursday, February 18, noted the significant opportunities for growth of the Bank based on the strong capabilities the Bank has built and the strong outlook for economic recovery in India, and has approved raising of funds for an amount aggregating up to Rs 3,000 crore, in one or more tranches," it said in an exchange filing. READ MORE

11:47 AM

SBI Cards m-cap tops Rs 1-trillion; Five factors that are driving the stock

With a market-capitalisation (m-cap) of Rs 1.02 trillion, State Bank of India-arm SBI Cards and Payment Services on Friday stood at 34th position in the overall m-cap ranking, BSE data showed. The firm’s m-cap is now more than that of Tata Motors, Shree Cement, and JSW Steel. READ MORE

11:36 AM

Sector Watch :: Nifty Metal index worst sectoral performer

11:29 AM

Magma Fincorp locked in 5% upper circuit; stock zooms 114% in 2 weeks

Shares of Magma Fincorp (MFL), on Friday, were locked in 5 per cent upper circuit at Rs 125.05; also its fresh 52-week high, on the BSE after rating agencies placed the rating of the company’s long/short term bank facilities on watch with developing implication. The trading volumes on the counter more-than-doubled with a combined 7.77 million equity shares changing hands on the NSE and BSE, till 11:02 am. READ MORE

11:19 AM

NEWS ALERT :: Aurobindo Pharma gets US FDA nod to manufacture & market Droxidopa Capsules

>> Capsules are used for the treatment of orthostatic dizziness & lightheadedness

11:09 AM

Wealthy PF investors may opt for debt funds as Budget changes tax rule

Wealthy investors who park their spare money in voluntary provident fund (VPF) accounts may consider moving to debt mutual funds after the Union Budget’s new proposals. Interest on provident fund (PF) was exempt from tax.

 

The Budget proposes that interest on the PF contributions (employee contribution) above Rs 2.5 lakh per annum be taxable with from April 1, 2021. READ MORE

11:02 AM

Recovery from early lows in today's trade

COMPANY	DAY'S LOW(RS)	DAY'S HIGH(RS)	LATEST(RS)	RISE(%)
New India Assura	177.00	197.00	195.70	10.56
Berger Paints	685.00	763.00	756.70	10.47
Capri Global	335.50	371.60	368.25	9.76
Poly Medicure	631.00	684.25	684.25	8.44

10:50 AM

NEWS ALERT :: Unichem Laboratories receives ANDA approval for Apremilast Tablets

The compnay received ANDA approval for its Apremilast Tablets, 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Amgen’s Otezla (apremilast) Tablets, 10 mg, 20 mg, and 30 mg. Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. 

10:47 AM

Dabur India shares decline 2% after block deals

Shares of Dabur India were trading 2 per cent lower at Rs 507.55 on the BSE in intra-day trade on Friday after nearly 10 million equity shares of the personal products company changed hands via block deals. At 09:15 am, around 9.63 million equity shares representing 0.54 per cent equity of Dabur India changed hands on the BSE, the exchange data shows. The name of the buyers and sellers were not known immediately. READ MORE

10:39 AM

BSE Smallcap gains 0.6%; gainers & losers from index

10:20 AM

Market Update :: Sensex erases early losses, trades flat